|
ALS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.891800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.965600E-04 |
| Normal-vs-Stage2 |
8.447200E-01 |
| Normal-vs-Stage3 |
3.657400E-01 |
| Normal-vs-Stage4 |
5.694400E-01 |
| Stage1-vs-Stage2 |
1.292390E-01 |
| Stage1-vs-Stage3 |
1.676440E-02 |
| Stage1-vs-Stage4 |
4.167600E-02 |
| Stage2-vs-Stage3 |
4.228200E-01 |
| Stage2-vs-Stage4 |
5.237000E-01 |
| Stage3-vs-Stage4 |
9.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.602060E-02 |
| Normal-vs-AfricanAmerican |
4.068000E-01 |
| Normal-vs-Asian |
4.197200E-01 |
| Caucasian-vs-AfricanAmerican |
4.282600E-01 |
| Caucasian-vs-Asian |
8.076000E-02 |
| AfricanAmerican-vs-Asian |
2.247200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.034100E-04 |
| Normal-vs-Female |
7.748300E-02 |
| Male-vs-Female |
2.05289999999358E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.141800E-01 |
| Normal-vs-Extreme_Weight |
1.85184000000005E-05 |
| Normal-vs-Obese |
6.601400E-01 |
| Normal-vs-Extreme_Obese |
2.080400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.064400E-02 |
| Normal_Weight-vs-Obese |
7.467600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.880800E-01 |
| Extreme_Weight-vs-Obese |
1.011880E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.800600E-01 |
| Obese-vs-Extreme_Obese |
1.568000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.593600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.419000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.778900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.486400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.396300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.74640000000426E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.384400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.956900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.454170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.856800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.296600E-03 |
| Normal-VS-Type2 PRCC |
1.288200E-01 |
| Normal-VS-KIRP CIMP |
1.562500E-02 |
| Normal-VS-Unclassified PRCC |
7.784200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.771800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.9521999999883E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
8.419800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.977200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.100200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.510020E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.144600E-01 |
| Normal-vs-N1 |
3.406500E-02 |
| Normal-vs-N2 |
3.440400E-01 |
| N0-vs-N1 |
2.076500E-03 |
| N0-vs-N2 |
1.416420E-01 |
| N1-vs-N2 |
8.672000E-01 |
|
|
